Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% Thymoquinone Gel for Gingivitis
NCT05497895Phase 1Unknown
- Sponsor
- King Abdulaziz University
- Start
- Sep 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of thymoquinone in gingivitis (3 arms), sponsored by King Abdulaziz University. Primary endpoints: Plaque Index at 2 weeks and Papillary Bleeding Index at 2 weeks. Status: unknown.
02
Drugs
thymoquinone
03
Conditions
gingivitis
Beyond the preview
Go deeper on NCT05497895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05497895.